BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7748534)

  • 1. Presence of HIV-1 proviral sequences in saliva of infected individuals in relation with clinical stage and CD4+ lymphocyte count.
    Liuzzi G; Chirianni A; Tullio Cataldo P; Conte MC; Barsanti LA; Ceccherini Nelli L; Piazza M
    Boll Soc Ital Biol Sper; 1994 Dec; 70(12):345-52. PubMed ID: 7748534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV-1 proviral DNA sequences in the saliva of patients with HIV infection].
    Piazza M; Chirianni A; Liuzzi G; Tullio Cataldo P; Santoro G; Barsanti L; Batoni G; Ceccherini Nelli L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):475-81. PubMed ID: 1362355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections.
    Sarr AD; Popper S; Thior I; Hamel DJ; Sankalé JL; Siby T; Marlink R; Essex M; Mboup S; Kanki P
    J Hum Virol; 1999; 2(1):45-51. PubMed ID: 10200599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
    Gueudin M; Damond F; Braun J; Taïeb A; Lemée V; Plantier JC; Chêne G; Matheron S; Brun-Vézinet F; Simon F
    AIDS; 2008 Jan; 22(2):211-5. PubMed ID: 18097223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells.
    Khadir A; Coutlée F; Saint-Antoine P; Olivier C; Voyer H; Kessous-Elbaz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):257-63. PubMed ID: 7788424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low copy numbers of HIV-1 proviral DNA in patient PBMCs by a high-input, sequence-capture PCR (Mega-PCR).
    Böni J; Shah C; Flepp M; Lüthy R; Schüpbach J
    J Med Virol; 2004 Jan; 72(1):1-9. PubMed ID: 14635004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential applications of proviral load measurement in clinical retrovirology.
    Conway B; Montpetit M; Raboud J; Salas T; Dufour D; Montaner JS; O'Shaughnessy MV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S45-50. PubMed ID: 7552512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
    Vitone F; Gibellini D; Schiavone P; Re MC
    J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
    Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
    Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients.
    Triantos D; Horefti E; Paximadi E; Kyriakopoulou Z; Karakassiliotis G; Papanastasiou K; Lelekis M; Panos G; Donta-Bakoyianni C; Rapidis A; Markoulatos P
    Oral Microbiol Immunol; 2004 Jun; 19(3):201-4. PubMed ID: 15107073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.
    Berry N; Ariyoshi K; Jaffar S; Sabally S; Corrah T; Tedder R; Whittle H
    J Hum Virol; 1998; 1(7):457-68. PubMed ID: 10195267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-course detection of HIV-1 proviral DNA and genomic RNA by polymerase chain reaction in sera from seropositive and seronegative hemophiliacs treated with clotting factor concentrates.
    Morita T; Kawabata H; Yanagihara Y; Horikoshi Y; Mimaya J
    Int J Hematol; 1993 Oct; 58(3):225-32. PubMed ID: 8148500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status.
    De Socio GV; Falcinelli C; Francisci D; Pauluzzi S; Cosmi EV; Anceschi MM
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):403-7. PubMed ID: 1670043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
    Yerly S; Kaiser L; Baumberger C; Hirschel B; Perrin LH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):358-64. PubMed ID: 7882100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.